A Study Assessing Circulation Around Surgical Incisions at the Time of Laparotomy Closure
- Conditions
- Laparotomy
- Registration Number
- NCT03408366
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Brief Summary
This study is being done to find out if Spectrum Near-Infrared (NIR) imaging with Indocyanine Green (ICG) dye can help measure blood flow around an incision before and after the surgeon closes the incision with staples or sutures.
The Spectrum NIR imaging system uses a handheld camera that produces a special type of light that can help surgeons see things during surgery that are difficult to see with the naked eye, for example, cancer tissue versus healthy tissue. Spectrum NIR imaging has been approved by the Food and Drug Administration (FDA) as a tool that is widely used during surgery.
ICG dye is a sterile solution that can be seen with Spectrum NIR imaging. This dye, used with Spectrum NIR imaging, allows surgeons to see blood flow to parts of the body during and after surgery. Making sure that there is enough blood flow to the surgical site helps to promote a less complicated recovery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 20
- Woman undergoing a laparotomy procedure via a vertical midline incision for any indication with the Gynecology Service at MSK
- Age ≥18 years
- Women with hepatic dysfunction as evidenced by elevated transaminases
- Women with a history of cirrhosis or other chronic liver disease
- Women with an allergy to iodine
- Women undergoing laparoscopic or minimally invasive surgery
Criteria for Eligibility Post-Surgery
Inclusion Criteria:
- Woman undergoing a laparotomy procedure via a vertical midline incision for any indication with the Gynecology Service at MSK
- Age ≥18 years
Subject Exclusion Criteria:
- Women with laparotomy incisions unable to be closed primarily due to tissue or fascial damage
- Women with transverse laparotomy incisions
- Women with laparotomy incisions left open due to a case classification as "contaminated" or "dirty"
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method percentage of cases with successful perfusion measurements 1 year Feasibility will be determined by the percentage of cases with successful perfusion measurements.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (8)
Memoral Sloan Kettering Basking Ridge (Consent only)
🇺🇸Basking Ridge, New Jersey, United States
Memoral Sloan Kettering Monmouth (Consent only)
🇺🇸Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen (Consent only )
🇺🇸Montvale, New Jersey, United States
Memorial Sloan Kettering Commack (Consent only)
🇺🇸Commack, New York, United States
Memoral Sloan Kettering Westchester (Consent only)
🇺🇸Harrison, New York, United States
Memorial Sloan Kettering Cancer Center
🇺🇸New York, New York, United States
Memorial Sloan Kettering Rockville Centre (Consent only)
🇺🇸Rockville Centre, New York, United States
Memorial Sloan Kettering Nassau (Consent only)
🇺🇸Uniondale, New York, United States
Memoral Sloan Kettering Basking Ridge (Consent only)🇺🇸Basking Ridge, New Jersey, United States